Insecticides (India) Ltd Board Approves FY26 Results, ESOP Scheme, and Director Changes
Insecticides (India) Limited approved FY26 audited results. The company formulated an Employee Stock Purchase Scheme 2026 for up to 2,00,000 shares. Mrs. Nikunj Aggarwal resigned as Whole Time Director. Mr. Sanskar Aggarwal was appointed Additional Whole Time Director, and Mr. Atul Kumar as VP - Sales (North). The 29th AGM is on August 12, 2026.
The approval of financial results and an employee stock option scheme are important for governance and employee motivation. The management changes, particularly the appointment of a new Whole Time Director, can have a medium-term impact on strategic direction and operations. The AGM date is also a key event.
The announcement includes routine financial results, the approval of an employee stock option plan, and changes in management (one resignation and one appointment). While these are significant events, they do not present a significantly positive or negative outlook on the company's immediate prospects.
Insecticides (India) Limited announced the outcome of its Board Meeting held on May 28, 2026. The Board approved the Audited Financial Results for the Quarter and Year ended March 31, 2026, along with the Auditor’s Report, which received an unmodified opinion. The company also approved the formulation of the Employee Stock Purchase Scheme 2026 (“IIL ESPS Scheme 2026”), which allows for the issuance of up to 2,00,000 Equity Shares, subject to shareholder approval at the upcoming 29th Annual General Meeting (AGM).
In terms of management changes, the Board took note of the resignation of Mrs. Nikunj Aggarwal as Whole Time Director with immediate effect. Subsequently, Mr. Sanskar Aggarwal was appointed as an Additional Whole Time Director for a term of five years, effective May 28, 2026, and also as a Director in its wholly-owned subsidiary, Kaeros Research Limited. Additionally, Mr. Atul Kumar was appointed as Vice President - Sales (North), a Senior Management Personnel (SMP), effective May 28, 2026. The Board also approved the appointment of M/s. T Jain & Associates as Internal Auditor for a period of five years, effective April 01, 2026, till March 31, 2031.
The 29th Annual General Meeting (AGM) of the Company is scheduled to be held on Wednesday, August 12, 2026, at 03:00 PM through Video Conferencing (VC). The Board meeting commenced at 01:00 PM (IST) and concluded at 04:15 PM (IST).
What to do with a filing like this
Insecticides (India) Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Insecticides (India) Limited. Read the original for the full detail.